Dimensional Fund Advisors Ltd. : Form 8.3 - Udg Healthcare Plc - Ordinary Shares
2021年8月13日 - 8:16PM
RNSを含む英国規制内ニュース (英語)
TIDMUDG
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing Dimensional Fund Advisors
(Note 1) Ltd. ("Dimensional"), in
its capacity as investment
manager and on behalf its
affiliates who are also
investment managers. Dimensional
and its affiliates expressly
disclaim beneficial ownership
of the shares described
in this form 8.3
-------------------------- ---------------------------------
Company dealt in UDG HEALTHCARE PLC
-------------------------- ---------------------------------
Class of relevant security EUR0.05 ordinary shares
to which the dealings
being disclosed relate
(Note 2)
-------------------------- ---------------------------------
Date of dealing 12 August 2021
-------------------------- ---------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long Short
--------------------------- ------------------- -------------
Number (%) Number (%)
--------------------------- ------------ ----- -------- ---
(1) Relevant securities 2,765,761 (1.10%)
--------------------------- ------------------- -------------
(2) Derivatives (other
than options)
--------------------------- ------------------- -------------
(3) Options and agreements
to purchase/sell
--------------------------- ------------------- -------------
Total 2,765,761 (1.10%)
--------------------------- ------------------- -------------
Please note there were net transfers in of 172 shares.
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
--------------------------- -------------- ---------------
Number (%) Number (%)
--------------------------- ------- --- -------- ---
(1) Relevant securities
--------------------------- -------------- ---------------
(2) Derivatives (other
than options)
--------------------------- -------------- ---------------
(3) Options and agreements
to purchase/sell
--------------------------- -------------- ---------------
Total
--------------------------- -------------- ---------------
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
-------------- ------------------------------ ---------------
Sale 17,220 GBP 10.7894
-------------- ------------------------------ ---------------
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
--------- --------------------- ------------------ ---------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
---------- ------------ -------------- -------- --------------- ------ --------------------
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
----------------- -------------------------- -------------------
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
--------------------- ------------- --------------------
N/A
--------------------- ------------- --------------------
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this
should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 13 August 2021
---------------------------- ----------------
Contact name Thomas Hone
---------------------------- ----------------
Telephone number +44 20 3033 3419
---------------------------- ----------------
If a connected EFM, name N/A
of offeree/offeror with
which connected
---------------------------- ----------------
If a connected EFM, state N/A
nature of connection (Note
10)
---------------------------- ----------------
(END) Dow Jones Newswires
August 13, 2021 07:16 ET (11:16 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Udg Healthcare Public (LSE:UDG)
過去 株価チャート
から 8 2024 まで 9 2024
Udg Healthcare Public (LSE:UDG)
過去 株価チャート
から 9 2023 まで 9 2024